Clinical trials sponsored by First Hospital of China Medical University

Phase breakdown

Conditions studied

Recruiting trials led by First Hospital of China Medical University

• Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
  NCT07503652 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
  NCT06637215 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
  NCT06696417 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation
  NCT07085650 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is First Hospital of China Medical University recruiting for?

First Hospital of China Medical University is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.